Clinical trial · Interventional
Research on New Diagnosis and Treatment Technologies for Early Lung Cancer
Research on New Intelligent Diagnosis and Treatment Technologies for Early Lung Cancer Based on Multimodal Imaging Bronchoscopy Navigation
NCT07000721CI-TRIAL-00091878completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To verify the clinical effectiveness and safety of the airway tree navigation system constructed by artificial intelligence (AI) in the navigation diagnosis of peripheral pulmonary nodules (PPLs).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer, Peripheral Pulmonary Nodules | Malignant Lung Neoplasm | CURATED_EXACT | 0.85 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Preoperative navigation path planning using the SARS-pro navigation system | Diagnostic Test | — | UNRESOLVED |
| Preoperative navigation path planning using the VBN navigation system | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- New navigation system group
- description
- The new AI-constructed airway tree navigation system (SARS-pro) was used for preoperative navigation path planning. The SARS-pro navigation system was independently developed by the research group based on a conventional augmented reality optical navigation system (LungPro; Bronchus Company).
- interventionNames
- Diagnostic Test: Preoperative navigation path planning using the SARS-pro navigation system
- type
- ACTIVE_COMPARATOR
- label
- Old navigation system group
- description
- Preoperative navigation path planning was performed using the old VBN system (LungPro; Bronchus Company).
- interventionNames
- Diagnostic Test: Preoperative navigation path planning using the VBN navigation system
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Aged 18 years or above. 2. Patients with one or more peripheral lung nodules suspected to be lung cancer or poorly absorbing lesions on conventional anti-infective therapy. 3. Patients with nodule diameters ≤30 mm (diameters mentioned in the text are the average of the maximum and minimum diameters). 4. The nodules were pure ground glass nodules, partially solid nodules, or solid nodules. 5. The nodule is surrounded by lung parenchyma and is not visible in the bronchial lumen above the segment. Exclusion Criteria: 1. Preoperative judgment that it is difficult for the patient to benefit from bronchoscopic biopsy (e.g., high risk of bleeding due to perivascular encasement of the lesion, difficulty in reaching the airway adjacent to the lesion due to previous lung surgery, etc.). 2. Those with incomplete clinical data. 3. Those with missing visits after biopsy.
References
Publications (0)
Data not yet available
No reference posted for this study.